![Douglas Swirsky](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Swirsky
Président chez
CELLECTAR BIOSCIENCES, INC.
Fortune : 100 593 $ au 31/05/2026
Profil
Mr. Douglas J.
Swirsky, CFA MBA, is a Chief Financial & Accounting Officer at Barinthus Biotherapeutics Plc and an Independent Chairman at Cellectar Biosciences, Inc. Mr. Swirsky was previously employed as a Chief Financial & Accounting Officer by MaxCyte, Inc., a Chairman by NeuroBo Pharmaceuticals, Inc., a Chief Financial Officer & Director by AavantiBio, Inc., a President, CEO, CFO, Secretary & Director by Rexahn Pharmaceuticals, Inc., an Independent Non-Executive Director by Pernix Therapeutics Holdings, Inc., a Chairman by Fibrocell Science, Inc., a Chairman by Castle Creek Biosciences, Inc., an Independent Director by PolyMedix, Inc., a President, CEO, Secretary & Director by GenVec, Inc., a Managing Director by Stifel, Nicolaus & Co., Inc., and a MD & Head-Life Sciences Investment Banking by Legg Mason, Inc. He received his undergraduate degree from Boston University and an MBA from Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MAXCYTE, INC. 0,08 % | 21/04/2026 | 82 919 ( 0,08 % ) | 100 332 $ | 31/05/2026 |
| 19/05/2026 | 83 ( 0 % ) | 261 $ | 31/05/2026 |
Postes actifs de Douglas Swirsky
| Sociétés | Poste | Début |
|---|---|---|
| CELLECTAR BIOSCIENCES, INC. | Président | 01/08/2017 |
| BARINTHUS BIOTHERAPEUTICS PLC | Directeur Financier/CFO | 01/05/2026 |
Anciens postes connus de Douglas Swirsky
| Sociétés | Poste | Fin |
|---|---|---|
| MAXCYTE, INC. | Directeur Financier/CFO | 30/03/2026 |
Aavantibio, Inc.
 Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | President | 01/10/2020 |
| METAVIA INC. | Président | 14/01/2022 |
| REXAHN PHARMACEUTICALS, INC. | Directeur Général | 01/11/2020 |
| FIBROCELL SCIENCE, INC. | Président | 13/12/2019 |
Formation de Douglas Swirsky
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Legg Mason, Inc.
 Legg Mason, Inc. Investment ManagersFinance Provides investment and asset management services | Finance |
Fibrocell Science, Inc.
 Fibrocell Science, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an autologous cell and gene therapy company focused on development of personalized biologics to treat rare skin and connective tissue diseases | Commercial Services |
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology Develops bio-pharmaceutical products | Health Technology |
MaxCyte, Inc.
 MaxCyte, Inc. BiotechnologyHealth Technology Specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of therapeutic products | Health Technology |
PolyMedix, Inc.
 PolyMedix, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic small molecule compound drugs | Health Technology |
Stifel, Nicolaus & Co., Inc.
 Stifel, Nicolaus & Co., Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Pernix Therapeutics Holdings, Inc.
 Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellectar Biosciences, Inc.
 Cellectar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer | Health Technology |
NeuroBo Pharmaceuticals, Inc.
 NeuroBo Pharmaceuticals, Inc. BiotechnologyHealth Technology Researches and develops disease-modifying therapies for neurodegenerative diseases | Health Technology |
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Health Technology |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Health Technology |
Vaccitech Plc
 Vaccitech Plc Pharmaceuticals: MajorHealth Technology Discovers and develops immunotherapeutic products and vaccines for the treatment and prevention of infectious and cancer diseases | Health Technology |
